Evaluating frequency, diagnostic quality, and cost of Lyme borreliosis testing in Germany: a retrospective model analysis.

Authors:
Address: Bacteriologic Infection Serology Study Group of Germany (BISSGG), Central Laboratory, Institute for Laboratory Medicine, Northwest Medical Centre, Academic Teaching Hospital, Medical Faculty, Johann Wolfgang Goethe-University, Steinbacher Hohl 2-26, 60488 Frankfurt am Main, Germany.
Journal:

Publication:
Free Text: Evaluating frequency, diagnostic quality, and cost of Lyme borreliosis testing in Germany: a retrospective model analysis.

abstract

BACKGROUND:

Data on the economic impact of Lyme borreliosis (LB) on European health care systems is scarce. This project focused on the epidemiology and costs for laboratory testing in LB patients in Germany.

MATERIALS AND METHODS:

We performed a sentinel analysis of epidemiological and medicoeconomic data for 2007 and 2008. Data was provided by a German statutory health insurance (DAK) company covering approx. 6.04 million members. In addition, the quality of diagnostic testing for LB in Germany was studied.

RESULTS:

In 2007 and 2008, the incident diagnosis LB was coded on average for 15,742 out of 6.04 million insured members (0.26%). 20,986 EIAs and 12,558 immunoblots were ordered annually for these patients. For all insured members in the outpatient sector, a total of 174,820 EIAs and 52,280 immunoblots were reimbursed annually to health care providers (cost: 2,600,850€). For Germany, the overall expected cost is estimated at 51,215,105€. However, proficiency testing data questioned test quality and standardization of diagnostic assays used.

CONCLUSION:

Findings from this study suggest ongoing issues related to care for LB and may help to improve future LB disease management.

Related Articles
Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification.
APMIS Suppl. 2002
Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification.
Lebech AM. APMIS Suppl. 2002; (105):1-40.
[Epidemiology and therapy of Lyme arthritis and other manifestations of Lyme borreliosis in Germany: results of a nation-wide survey].
Z Rheumatol. 2003
[Epidemiology and therapy of Lyme arthritis and other manifestations of Lyme borreliosis in Germany: results of a nation-wide survey].
Priem S, Munkelt K, Franz JK, Schneider U, Werner T, Burmester GR, Krause A. Z Rheumatol. 2003 Oct; 62(5):450-8.
Surveillance of Lyme borreliosis in Germany, 2002 and 2003.
Euro Surveill. 2005
Surveillance of Lyme borreliosis in Germany, 2002 and 2003.
Mehnert WH, Krause G. Euro Surveill. 2005 Apr; 10(4):83-5.
Review Epidemiological studies of Lyme borreliosis and tick-borne encephalitis.
Scand J Infect Dis Suppl. 1994
Review Epidemiological studies of Lyme borreliosis and tick-borne encephalitis.
Gustafson R. Scand J Infect Dis Suppl. 1994; 92:1-63.
Review [Lyme borreliosis--diagnostic difficulties in interpreting serological results].
Med Pregl. 2010
Review [Lyme borreliosis--diagnostic difficulties in interpreting serological results].
Gajović O, Todorović Z, Nesić L, Lazić Z. Med Pregl. 2010 Nov-Dec; 63(11-12):839-43.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.